SCHEMBL24510052

SCHEMBL24510052

N#Cc1ccc(-c2c(-n3c4ccccc4c4ccccc43)c(-n3c4ccccc4c4ccccc43)c(-n3c4ccccc4c4c3ccc3c5ccccc5n(-c5ccccc5)c34)c(-n3c4ccccc4c4ccccc43)c2-n2c3ccccc3c3ccccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ KMT2A Q03164 2/20 0.34
▸ USP14 P54578 2/20 0.32
▸ AR P10275 1/20 0.32
▸ PGR P06401 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ PDPK1 O15530 1/20 0.31
▸ PDE9A O76083 1/20 0.31
▸ PDE1C Q14123 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ G6PD P11413 1/20 0.30
▸ ALOX5 P09917 1/20 0.30
▸ PTGS2 P35354 1/20 0.30
▸ PTGER4 P35408 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24510015 0.97 ATM (0.41) ATMKDM4EL3MBTL1KMT2AUSP14
SCHEMBL21950730 0.92 KDM4E (0.36) ATMKDM4EL3MBTL1KMT2AUSP14
SCHEMBL24510039 0.91 KDM4E (0.39) ATMKDM4EL3MBTL1KMT2APGR
SCHEMBL24509796 0.91 ATM (0.41) ATMKDM4EL3MBTL1KMT2AUSP14
SCHEMBL17297077 0.89 ATM (0.45) ATMKDM4EL3MBTL1KMT2AUSP14
SCHEMBL21950282 0.89 KDM4E (0.38) ATMKDM4EL3MBTL1KMT2AUSP14
SCHEMBL24510081 0.89 KDM4E (0.37) ATMKDM4EL3MBTL1KMT2APGR
SCHEMBL24509846 0.88 ATM (0.42) ATMKDM4EL3MBTL1KMT2AUSP14
SCHEMBL26473248 0.88 KDM4E (0.49) ATMKDM4EL3MBTL1USP14G6PD
SCHEMBL24509844 0.86 ATM (0.41) ATMKDM4EL3MBTL1KMT2AUSP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220185824-A1 PI-CONJUGATED COMPOUND, METHOD FOR PRODUCING PI-CONJUGATED COMPOUND, INK COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, LIGHT EMITTING MATERIAL, CHARGE TRANSPORT MATERIAL, LIGHT EMITTING FILM AND ORGANIC ELECTROLUMINESCENT ELEMENT Konica Minolta, Inc. (JP) 2022-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185824-A1 PI-CONJUGATED COMPOUND, METHOD FOR PRODUCING PI-CONJUGATED COMPOUND, INK COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, LIGHT EMITTING MATERIAL, CHARGE TRANSPORT MATERIAL, LIGHT EMITTING FILM AND ORGANIC ELECTROLUMINESCENT ELEMENT NAP1L1, XPO6, INTS6 ATM 2901/4885KDM4E 3483/4885L3MBTL1 1836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback